DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 3NanoAlvand
03 1Octavius Pharma Pvt. Ltd
04 11Pharmathen SA
05 6Strides Pharma Science
06 242care4
07 6AMN Life Science
08 10Abacus Medicine
09 18Accord healthcare
10 4Adcock Ingram
11 3Ajanta Pharma Limited
12 3Akriti Pharmaceuticals Pvt. Ltd.
13 3Alkem Laboratories
14 8Alphapharm PTY Ltd
15 6Aps-Arzneimittel-Parallelimport-Service Ag
16 12Arrow Pharmaceuticals
17 4Ascent Innovative Medicines
18 119Astellas Pharma
19 1Avet Pharmaceuticals
20 3Biocon
21 2Boston Pharma
22 3CHENGDU
23 6CHIESI USA INC
24 2Cantabria Labs
25 10Chiesi Group
26 1Chongqing Huapont Pharmaceutical
27 3Cinfa
28 3Cipla Medpro South Africa
29 3Concord Biotech
30 2Dermapharm Holding
31 2Difa Cooper
32 4EG Spa
33 3ENDO OPERATIONS LTD.
34 2EQL Pharma
35 25Ebb Medical
36 2Eldroga
37 1Encube Ethicals
38 3Farm Agon
39 2Farmatek
40 3Finno Medical Limited
41 4Focelite
42 2Fougera Pharmaceuticals Inc.
43 1Galenica Ab
44 1Galenicum
45 5Glenmark Pharmaceuticals
46 3Hangzhou Zhongmei Huadong Pharmaceutical
47 1Hospira, Inc.
48 1Indiana Ophthalmics
49 7Intas Pharmaceuticals
50 3Ivax Scandinavia Ab
51 3Jiangsu Hengrui Medicine
52 3Karo Pharma
53 23Leo Pharma
54 4Madras Pharmaceuticals
55 41Medartuum
56 3Medipol Pharmaceutical
57 3Murli Krishna Pharma
58 3Naprod Life Sciences
59 1Nexus Pharmaceuticals
60 2Northern Medical Group Aps
61 67ORIFARM GROUP AS
62 2Omnia Mutantur Pharmaceuticals Ab
63 9Panacea Biotec Limited
64 30Paranova Pharmaceuticals Ab
65 9Pharmachim Ab
66 12Pharmacore Inc
67 3Pierre Fabre
68 3Pinnacle Life Science
69 3RPG Life Sciences
70 1SKNV
71 6STADA Arzneimittel
72 87Sandoz B2B
73 2Smith & Kenner Pharmaceuticals
74 3Strides Pharma SA (Pty) Ltd
75 33Teva Pharmaceutical Industries
76 11Unimedic AB
77 1United Biotech
78 3Veloxis Pharmaceuticals
79 6Viatris
80 2West-Coast Pharmaceuticals
81 3World Medicine
82 3XYZ Pharma
01 30CAP
02 4CAPSULE
03 4CAPSULE (EXTENDED RELEASE)
04 6CAPSULE (IMMEDIATE RELEASE)
05 6CAPSULE, EXTENDED RELEASE;ORAL
06 40CAPSULE;ORAL
07 285Capsule
08 16Capsule, hard
09 9Capsules
10 3Caspule
11 1Concentrate For Infusion Solution
12 2Concentrate For Solution For Infusion
13 1Concentrate to the infusion fluid
14 2Cream
15 1Cutaneous Emulsion
16 3Depot tablet
17 3ER Capsule
18 4Extended Release Capsule
19 4Extended Release Capsules
20 1Extended Release Hard Capsules
21 1Extended Release Tablet
22 22Extended-Release Hard Capsule
23 4Extended-Release Tablet
24 4Eye Ointment
25 2FOR SUSPENSION;ORAL
26 6Granule For Oral Suspension
27 2Granules to potion, suspension
28 20Hard Capsule
29 9Hard Capsules
30 6Hard Capsules With Extended Release
31 1Hard Capsules With Extended Release-Oral
32 1Hard Capsules With Prolonged Release
33 4Hard Gelatin Capsule
34 1Hard Release Capsules
35 2Hard Release Capsules - Oral
36 1INJ
37 3INJECTABLE;INJECTION
38 1Injection
39 3Modified Release Capsule
40 1Modified Release Tablet
41 4OIN
42 4OINTMENT
43 9OINTMENT;TOPICAL
44 25Ointment
45 3Oral Solid Dosage Form
46 3Pellets For Capsule
47 1Pellets/Micro pellets for capsules
48 8Pit capsule, hard
49 4Prolonged Release Hard Capsule
50 1SOLUTION
51 21Salve
52 1Skin Emulsion
53 3Sustained Release Capsule
54 3TABLET (EXTENDED-RELEASE)
55 3TABLET, EXTENDED RELEASE;ORAL
56 7Tablet
57 1Tacrolimus 0.03% 10G Ointment Dermatological Use
58 1Tacrolimus 0.03% 30G Ointment Dermatological Use
59 1Tacrolimus 0.1% 10G Ointment Dermatological Use
60 1Tacrolimus 0.1% 30G Ointment Dermatological Use
61 5Tacrolimus 0.5Mg 30 Joined' Oral Use
62 1Tacrolimus 0.5Mg 30 Joined' Oral Use Rp
63 1Tacrolimus 0.75Mg 30 Joined' Oral Use
64 1Tacrolimus 0.75Mg 30 Joined' Oral Use Rp
65 5Tacrolimus 1Mg 60 Units Oral Use
66 1Tacrolimus 1Mg 60 Units Oral Use Rp
67 1Tacrolimus 1Mg/Die 60 Units Oral Use Rp
68 1Tacrolimus 2Mg 30 Joined' Oral Use
69 1Tacrolimus 3Mg 30 Joined' Oral Use Rp
70 1Tacrolimus 4Mg 30 Joined' Oral Use Rp
71 1Tacrolimus 5Mg 10 Units Parenteral Use
72 4Tacrolimus 5Mg 30 Joined' Oral Use
73 1Tacrolimus 5Mg 30 Joined' Oral Use Rp
74 1Vial
75 56capsule
76 42Blank
01 29Allowed
02 100Approved
03 48Authorized
04 4Cancelled
05 5DISCN
06 169Deregistered
07 22Generic
08 3Lead Market Dossiers- Approved in US
09 3Lead Market Dossiers- Filed
10 14Originator
11 19Prescription
12 58RX
13 3USA
14 269Blank
01 3ACH-TACROLIMUS
02 3ADOPORT
03 4ADVAGRAF
04 16ADVAGRAF XL
05 4ADVAGRAPH
06 3ASTAGRAF XL
07 31Adoport
08 3Adport
09 25Advagraf
10 1Advagraf 0,5 mg
11 1Advagraf 1 mg
12 1Advagraf 5 mg
13 29Advertisement
14 2CARELIMUS
15 4CONFEROPORT
16 2Cellmune
17 5Conferoport
18 5Crilomus
19 25Dailiport
20 1ELTACRO - 0.5mg
21 1ELTACRO - 1
22 3ENVARSUS PA
23 3ENVARSUS XR
24 16Envarsus
25 1Graftac 0,5
26 1Graftac 0,5 Prolonged Release
27 1Graftac 1
28 1Graftac 1 Prolonged Release
29 1Graftac 5
30 1Graftac 5 Prolonged Release
31 4I Adopt
32 2Modes Graph
33 4Modigraf
34 2Modigraph
35 1Nuju Cream
36 13PROGRAF
37 6PROTOPIC
38 8Pacrolim
39 4Pharmacor Tacrolimus 0.5
40 4Pharmacor Tacrolimus 1
41 4Pharmacor Tacrolimus 5
42 3Pragraf
43 37Prograf
44 2Prograf 0,5 mg
45 2Prograf 1 mg
46 2Prograf 5 mg
47 1Prograf Concentrate for Infusion
48 3Prograft
49 4Program
50 102Prograph
51 13Protopic
52 2Protopic
53 2Protopic 0,03% Ointment
54 2Protopic 0,1% Ointment
55 2Protopic 0.03% Ointment
56 2Protopic 0.1% Ointment
57 2Protopy
58 1Qvaya
59 4Roltisa
60 3SANDOZ TACROLIMUS
61 3Suprotac
62 4TACFORIUS
63 1TACIM-0.5 CAPSULE
64 1TACIM-1 CAPSULE
65 3TACNI
66 1TACROLIM 0,03%
67 1TACROLIM 0,1%
68 49TACROLIMUS
69 4TACROLIMUS EG
70 1TACRUM 0,5 mg
71 1TACRUM 1 mg
72 1TACRUM 5 mg
73 2TAKROLADA
74 8Tacforius
75 1Tacgalen
76 27Tacni
77 1Tacrocutan
78 1Tacrocutan g
79 12Tacrograf
80 4Tacrolimus
81 1Tacrolimus 0,5 Teva
82 1Tacrolimus 1 Teva
83 14Tacrolimus 2Care4
84 1Tacrolimus 5 Teva
85 4Tacrolimus Accord
86 3Tacrolimus Actavis
87 3Tacrolimus Cinfa
88 2Tacrolimus Eql
89 3Tacrolimus IR
90 14Tacrolimus Orifarm
91 20Tacrolimus Sandoz
92 2Tacrolimus Stada
93 4Tacrolimus Stadafarma
94 16Tacrolimus XR Sandoz
95 5Tacrolus
96 2Takrolimus Abacus Medicine
97 3Takrolimus Accord
98 4Takrolimus Ebb
99 3Takrozem
100 1Takrozem g
101 1Talomune 0,5 mg
102 1Talomune 1 mg
103 1Talomune 5 mg
104 3TarcoPol
105 1Tarograf 0.5
106 1Tarograf 1
107 1Tarograf 5
108 1Tevligraf 0,5
109 1Tevligraf 1
110 1Tevligraf 5
111 64Blank
01 96Australia
02 19Canada
03 4China
04 7Greece
05 64India
06 3Iran
07 59Italy
08 35Norway
09 35South Africa
10 52Spain
11 269Sweden
12 29Switzerland
13 5Turkey
14 1U.S.A
15 63USA
16 2Vietnam
17 3Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Suprotac
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Tacrolimus
Dosage Form : Pellets/Micro pellets for capsules
Dosage Strength : 0.5; 1; 5%; %; %
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : TACROLIMUS
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2014-07-22
Application Number : 90687
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Suprotac
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Suprotac
Dosage Form : Vial
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Hard Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Hard Capsule
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Extended Release Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Extended Release Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Extended Release Capsule
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Roltisa
Dosage Form : Extended-Release Hard Capsule
Dosage Strength : 1MG
Packaging :
Approval Date : 2022-10-14
Application Number : 88195
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Roltisa
Dosage Form : Extended-Release Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date : 2022-10-14
Application Number : 88196
Regulatory Info : Authorized
Registration Country : Spain
